86% of All Health Care and Device Companies Report Clinical Operations Groups Involvement in Risk-Based Monitoring Activities RESEARCH TRIANGLE PARK, NC--(Marketwired - October 25, 2016) - Although drug and device companies do not view dedicated risk-based monitoring (RBM) teams as a necessity, their clinical operations...